Company: CMND
Filing Date: 2025-11-19
Form Type: 424B5
Source: 0001213900-25-112329
Chunk: 38

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-19
Form: 424B5
Chunk 38
---
 this prospectus, and the reference to our website in this prospectus is an inactive textual reference only.

<div align='center'>5

RISK FACTORS</div>

Investing in our securities
involves significant risks. Before making an investment decision, you should carefully consider the risks described under “Risk
Factors” in the applicable prospectus supplement and under Item 3.D. – “Risk Factors” in our most recent Annual
Report on Form 20-F, or any updates in our Reports on Form 6-K, together with all of the other information appearing in this prospectus
or incorporated by reference into this prospectus and any applicable prospectus supplement, in light of your particular investment objectives
and financial circumstances. The risks so described are not the only risks facing us. Additional risks not presently known to us or that
we currently deem immaterial may also impair our business operations. Our business, financial condition and results of operations could
be materially adversely affected by any of these risks. The trading price of our securities could decline due to any of these risks, and
you may lose all or part of your investment. The discussion of risks includes or refers to forward-looking statements; you should read
the explanation of the qualifications and limitations on such forward-looking statements discussed elsewhere in this prospectus.

Part of our operations are conducted in Israel. Conditions in Israel, including the recent attack by Hamas and other terrorist organizations and Israel’s war against them, may affect our operations.

Our headquarters and a portion
of our operations are located in the State of Israel. In addition, certain of our key employees and officers, including our chief executive
officer, are residents of Israel. Accordingly, political, economic and military conditions in Israel and the surrounding region may directly
affect our business.

Any hostilities involving
Israel or the interruption or curtailment of trade between Israel and its present trading partners, or a significant downturn in the economic
or financial condition of Israel, could affect adversely our operations. Ongoing and revived hostilities or other Israeli political or
economic factors could harm our operations, product development and results of operations.

On October 7, 2023, an unprecedented
attack was launched against Israel by terrorists from the Hamas terrorist organization that infiltrated Israel’s southern border
from the Gaza Strip and in other areas within the state of Israel attacking civilians and military targets while simultaneously launching
extensive rocket attacks on the Israeli population. These attacks resulted in extensive deaths, injuries and kidnapping of civilians and
soldiers